Posters
Ab interno canaloplasty combined with phacoemulsification and Ab interno canaloplasty standalone in controlled glaucoma
Poster Details
First Author: J.Izquierdo Villavicencio PERU
Co Author(s): C. Gajardo Menzel M. Rincon Sanchez K. Ruiz Montenegro J. Lopez Aliendres C. Ponte Dávila
Abstract Details
Purpose:
To evaluate the outcomes of micropulse transscleral cyclophotocoagulation for intraocular pressure (IOP) control in patients with penetrating keratoplasty and Boston keratoprosthesis.
To evaluate the efficacy and safety Ab interno canaloplasty combined phacoemulsification and the Ab interno canaloplasty as stand-alone procedure in patients with medically controlled open angle glaucoma.
Setting:
Instituto de Ojos Oftalmosalud
Methods:
This comparative non-randomized retrospective study evaluated the 12-month outcomes of patients with medically controlled open angle glaucoma who underwent combined phacoemulsification with Ab interno canaloplasty and Ab interno canaloplasty as a stand- alone procedure. The primary outcome was mean preoperative and postoperative intraocular pressure; the secondary outcomes included the reduction in number of glaucoma medications, visual acuity, and complications.
Results:
07 eyes of sixty-three patients were included; intraocular pressure was 16.19±7.92 mmHg and 17.10±6.68 mmHg for group Phaco and ABiC and stand-alone ABiC group respectively at baseline, and 10.84±1.57 mmHg (p<0.001) and 11.41±1.65 mmHg (p=0.003), respectively at the 12-month follow-up. Medications decreased from 2.2±1.7 to 0.2±0.6 (p<0.001) in group Phaco and ABiC; 82% of eyes were medication free. In the stand-alone ABiC group medications decreased from 2.7±1.3 to 0.7±1.2 (p < 0.001); 63% of eyes were medication free at 12 months. Visual acuity outcomes and complication rates were similar between the 2 groups.
Conclusions:
Both groups achieved efficient and safe reduction in intraocular pressure as observed in patients with medically controlled open angle glaucoma at the 12-month follow up. The canaloplasty ab interno was effective at reducing the mean intraocular pressure and glaucoma medications with or without cataract surgery.
Financial Disclosure:
None